Ibogaine can interact with antidepressants through changes in drug metabolism, overlapping cardiac effects, and serotonergic activity. The risks depend on the specific medication and the person’s medical history. Stopping an antidepressant introduces separate risks, so neither combining nor discontinuing these medicines should be decided using a generic online schedule.
Can You Take Ibogaine While on Antidepressants?
Taking an antidepressant raises more than one question when considering ibogaine. A medicine may affect how ibogaine is processed, have its own cardiac effects, or act on overlapping neurotransmitter systems. Stopping or switching that medicine can also create withdrawal symptoms or destabilize the condition it treats. These are separate issues, and a clinic's blanket instruction to "stop antidepressants" does not explain which interaction is being addressed or how the risks of stopping will be managed.
SSRIs, SNRIs, tricyclic antidepressants, MAO inhibitors, and other antidepressants have different properties, and even medicines within one class differ. The relevant information includes the exact drug, actual use, recent changes, other substances, and the condition being treated. An interaction review should use that specific information rather than classify a medicine as safe because another person took it or because it is absent from a website's warning list. Our drug-interaction resource can introduce topics to discuss, but it cannot resolve an individual medication decision.
How Antidepressants Can Affect Ibogaine Metabolism: CYP2D6
Ibogaine is converted to noribogaine substantially through CYP2D6. In a 2015 study of 21 healthy volunteers, researchers compared ibogaine exposure after pretreatment with placebo or paroxetine, a CYP2D6 inhibitor. Combined exposure to ibogaine and noribogaine was substantially greater in the paroxetine-pretreated group. This was a small, low-exposure pharmacology study in healthy participants; it did not validate combining paroxetine with an addiction-treatment regimen, establish a safe waiting period, or determine the risk of every antidepressant. Its practical contribution is direct evidence that an antidepressant can materially alter ibogaine exposure.
A later analysis in patients with opioid use disorder also related ibogaine clearance to CYP2D6 genotype. Genetic metabolism and medication effects are related questions, but a genotype result does not evaluate every interaction or replace a clinical review. Someone may therefore need assessment even when their prescribed antidepressant dose has been stable for years: stability on one medicine does not establish what happens when another substance is introduced.
Ibogaine, Antidepressants and QT Prolongation
Some antidepressants have recognized effects on the QT interval. Ibogaine also has documented effects on cardiac repolarization; see our guide to ibogaine and QT prolongation. The relevant concern is not whether antidepressants are harmful as a category; it is whether a particular proposed exposure adds risk for a particular person. Do not use a normal baseline ECG to settle that question on your own; it records the heart's electrical activity at the time of testing, it does not demonstrate the response to a later combination. Let a qualified clinician interpret the actual tracing and medication history, and make sure the review covers medicines used occasionally or proposed during admission, not just the daily antidepressant.
Can Ibogaine and Antidepressants Cause Serotonin Syndrome?
Laboratory and structural research demonstrates interactions between ibogaine and the serotonin transporter, which helps explain why serotonergic combinations warrant attention. That is not a clinical study measuring serotonin syndrome after ibogaine plus an antidepressant. Fluoxetine's own prescribing information warns about serotonin syndrome with other serotonergic agents and identifies CYP2D6 inhibition and prolonged elimination as relevant factors. These are reasons for a careful medicine-specific assessment, not grounds for inventing an ibogaine-specific percentage or applying a waiting period from a different drug combination.
A targeted search did not identify reliable incidence data establishing the risk of serotonin syndrome across the various ibogaine-antidepressant combinations. That uncertainty should remain visible. It does not prove combining them is safe, and it does not justify claiming a severe reaction is inevitable. If someone becomes acutely unwell after a substance exposure, seek medical assessment rather than trying to distinguish toxicity, withdrawal, or a psychiatric episode using an online symptom comparison.
Should You Stop Antidepressants Before Ibogaine?
Abrupt stopping or missed doses of an antidepressant can cause withdrawal symptoms, including dizziness, anxiety, sleep disturbance, and altered sensations, and severity and duration vary. A difficult preparation period should not automatically be interpreted as a necessary step toward ibogaine or evidence that the underlying illness has resolved. Ask what support would be available if symptoms worsen or admission is postponed, and who will review the person afterward if a medicine is changed. A clinic's discharge suggestion is not a substitute for a coordinated prescribing plan.
Do not stop, restart, or substitute an antidepressant based on this article or a generic online schedule. Involve the clinician responsible for treating the condition.
Questions to Ask About Antidepressants Before Ibogaine Treatment
Ask for the medical rationale behind any medication instruction: which risk is the clinic addressing, what evidence supports its approach, and who has reviewed your complete list. Request a plan for the possibility that treatment does not proceed, since preparatory medication changes can still have consequences when an intervention is cancelled. Finally, ask whether the program will support ongoing psychiatric treatment after discharge. Integration and psychiatric follow-up have different functions, and wanting continued treatment should be part of the discussion from the beginning.